Current Hypertension Reports

Adrenomedullin in hypertension

Richard D. Troughton, John G. Lainchbury, David O. McGregor, A. Mark Richards, M. Gary Nicholls

Web alert

Literature alert

Xenobiotics, dietary interventions, and genetically mediated therapies

Nicholas J. Schork

Selecting the right drug for initial antihypertensive therapy

Alan B. Weder

Heredity and the autonomic nervous system in human hypertension

Daniel T. O’Connor, Paul A. Insel, Michael G. Ziegler, Vivian Y. Hook, Douglas W. Smith, Bruce A. Hamilton, Palmer W. Taylor, Robert J. Parmer

Use of single nucleotide polymorphisms for gene discovery in hypertension

Myriam Fornage, Peter A. Doris

Context-dependent genetic effects in hypertension

Sharon L. R. Kardia

The role of β2-adrenergic receptor variation in human hypertension

Molly S. Bray, Eric Boerwinkle

Hypertension and single nucleotide polymorphisms

Mark J. Rieder, Deborah A. Nickerson

Genetic contributions to left ventricular hypertrophy

Donna K. Arnett

Hope gives reason for hope

Ernesto L. Schiffrin

Gene therapy at the clinical horizon?

Thomas F. Lüscher

Antihypertensive drugs and reversing of endothelial dysfunction in hypertension

Stefano Taddei, Agostino Virdis, Lorenzo Ghiadoni, Isabella Sudano, Antonio Salvetti

Carotid intima-media thickness as a measure of vascular target organ damage

G. B. John Mancini

Role of adhesion molecules in vascular regulation and damage

Anitaben Tailor, D. Neil Granger

Endothelial dysfunction and atherosclerosis: Endothelin receptor antagonists as novel therapeutics

Matthias Barton

Gene therapy of hypertensive vascular injury

Yi Chu, Frank M. Faraci, Donald D. Heistad

Oxidative stress and vascular damage in hypertension

Rhian M. Touyz

Regulation of matrix proteins and impact on vascular structure

José Tuñón, Marta Ruiz-Ortega, Jesús Egido